Cargando…
Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment
Alzheimer’s disease (AD) is an age-related and progressive neurodegenerative disorder. It is widely accepted that AD is mainly caused by the accumulation of extracellular amyloid β (Aβ) and intracellular neurofibrillary tau tangles. Aβ begins to accumulate years before the onset of cognitive impairm...
Autores principales: | Nakai, Tsuyoshi, Yamada, Kiyofumi, Mizoguchi, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197360/ https://www.ncbi.nlm.nih.gov/pubmed/34074018 http://dx.doi.org/10.3390/ijms22115549 |
Ejemplares similares
-
Matrix Metalloproteinases Contribute to Neuronal Dysfunction in Animal Models of Drug Dependence, Alzheimer's Disease, and Epilepsy
por: Mizoguchi, Hiroyuki, et al.
Publicado: (2011) -
Pharmacologic Treatment with GABA(B) Receptor Agonist of Methamphetamine-Induced Cognitive Impairment in Mice
por: Mizoguchi, Hiroyuki, et al.
Publicado: (2011) -
New Strategies for the Treatment of Neuropsychiatric Disorders Based on Reelin Dysfunction
por: Tsuneura, Yumi, et al.
Publicado: (2022) -
Roles of Matrix Metalloproteinases and Their Targets in Epileptogenesis and Seizures
por: Mizoguchi, Hiroyuki, et al.
Publicado: (2013) -
Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune Activation
por: Ibi, Daisuke, et al.
Publicado: (2015)